{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:26:26Z","timestamp":1769016386906,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ahjo.2025.100701","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:46:06Z","timestamp":1765989966000},"page":"100701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential effects of pre-procedural atorvastatin versus rosuvastatin on hematologic and inflammatory markers in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized controlled trial"],"prefix":"10.1016","volume":"61","author":[{"given":"Ramin","family":"Khameneh Bagheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Eshraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Amirsoleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faeze","family":"Keihanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahjo.2025.100701_bb0005","series-title":"Mayo Clinic Proceedings","article-title":"Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology","year":"2009"},{"issue":"suppl_1","key":"10.1016\/j.ahjo.2025.100701_bb0010","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/ndt\/gfl213","article-title":"The clinical and renal consequences of contrast-induced nephropathy","volume":"21","author":"Finn","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.ahjo.2025.100701_bb0015","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100701_bb0020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjcard.2009.10.044","article-title":"Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome","volume":"105","author":"Senoo","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ahjo.2025.100701_bb0025","first-page":"177","article-title":"Contrast-induced nephropathy (CIN) consensus working panel: executive summary","volume":"7","author":"McCullough","year":"2006","journal-title":"Rev. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100701_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/tri.12191","article-title":"Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer","volume":"27","author":"Lai","year":"2014","journal-title":"Transpl. Int."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100701_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/tri.12191","article-title":"Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer","volume":"27","author":"Lai","year":"2014","journal-title":"Transpl. Int."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100701_bb0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000371496","article-title":"Association between platelet-to-lymphocyte ratio and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome","volume":"5","author":"Demircelik","year":"2015","journal-title":"Cardiorenal Med."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100701_bb0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjcard.2009.10.044","article-title":"Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome","volume":"105","author":"Senoo","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ahjo.2025.100701_bb0050","article-title":"Comparison of atorvastatin and rosuvastatin on preventing contrast-induced-nephropathy in patients undergoing primary percutaneous coronary intervention: a multi-centric randomized triple-blind clinical trial","volume":"17","author":"Bagheri","year":"2021","journal-title":"Signa Vitae"},{"issue":"4","key":"10.1016\/j.ahjo.2025.100701_bb0055","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.amjcard.2010.03.062","article-title":"Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction","volume":"106","author":"Azab","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100701_bb0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjcard.2012.11.012","article-title":"Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"111","author":"Park","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100701_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11883-000-0022-3","article-title":"Pleiotropic effects of statins","volume":"2","author":"Farmer","year":"2000","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100701_bb0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MOL.0b013e3283453e41","article-title":"Mechanisms for the anti-inflammatory effects of statins","volume":"22","author":"Bu","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"issue":"21\u221222","key":"10.1016\/j.ahjo.2025.100701_bb0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17520363.2024.2415284","article-title":"The role of systemic immune-inflammatory index in predicting contrast-induced nephropathy in non-ST-segment elevation myocardial infarction cases","volume":"18","author":"Tezen","year":"2024","journal-title":"Biomark. Med."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100701_bb0080","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/pace.14436","article-title":"Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction","volume":"45","author":"Hay\u0131ro\u011flu","year":"2022","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ahjo.2025.100701_bb0085","article-title":"Prognostic value of inflammatory indices for atrial fibrillation recurrence after cryoablation: a cohort study","volume":"12\u20132025","author":"Jie","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.ahjo.2025.100701_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11239-006-9014-7","article-title":"Platelet count, mean platelet volume, platelet distribution width, and plateletcrit do not correlate with optical platelet aggregation responses in healthy volunteers","volume":"22","author":"Beyan","year":"2006","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.ahjo.2025.100701_bb0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1538-7836.2009.03584.x","article-title":"Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis","volume":"8","author":"Chu","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100701_bb0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. - basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ. J."},{"issue":"23","key":"10.1016\/j.ahjo.2025.100701_bb0105","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/eurheartj\/ehu063","article-title":"Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy","volume":"35","author":"Narula","year":"2014","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ahjo.2025.100701_bb0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/AC.68.5.2994472","article-title":"Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial)","volume":"68","author":"Kaya","year":"2013","journal-title":"Acta Cardiol."},{"issue":"10","key":"10.1016\/j.ahjo.2025.100701_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111124","article-title":"Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.ahjo.2025.100701_bb0120","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1161\/CIRCULATIONAHA.112.103317","article-title":"Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury","volume":"126","author":"Quintavalle","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahjo.2025.100701_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"Leoncini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ahjo.2025.100701_bb0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.amjcard.2007.05.044","article-title":"Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg\/L) and low-density lipoprotein cholesterol (< 70 mg\/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study)","volume":"100","author":"Betteridge","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ahjo.2025.100701_bb0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","article-title":"Optimized treatment of ST-elevation myocardial infarction","volume":"125","author":"Niccoli","year":"2019","journal-title":"Circ. Res."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602225002046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602225002046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:45:05Z","timestamp":1768963505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602225002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S2666602225002046"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2025.100701","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of pre-procedural atorvastatin versus rosuvastatin on hematologic and inflammatory markers in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2025.100701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100701"}}